You are here
- Home
- Therapy Areas
- Respiratory/Inflammation
A Phase I, Single Centre, Double-blind, Randomised, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Inhaled AZD8683 After Single Ascending Doses in Healthy Male Subjects
- Disease
- asthma
- Drug Name
- AZD8683
- Generic Name
- AZD8683
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Oct 20, 2009
- Study Name
- D1883C00001
- Study Id
- D1883C00001
- ClinicalTrials.gov ID
- NCT00979849
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
